We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$4.36B
Cap. Flow %
81.59%
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.34%
2 Consumer Staples 15.45%
3 Real Estate 13.97%
4 Consumer Discretionary 7.8%
5 Healthcare 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IYR icon
301
iShares US Real Estate ETF
IYR
$4.16B
$1.2M 0.02%
+18,083
New +$1.28M
2013 Q2
0 quarters
ALBO
302
DELISTED
Albireo Pharma Inc
ALBO
$1.13M 0.02%
+9,000
New +$936K
2013 Q2
0 quarters
WNC icon
303
Wabash National
WNC
$538M
$1.07M 0.02%
+105,515
New +$1.02M
2013 Q2
0 quarters
CNC icon
304
Centene
CNC
$32.3B
$1.05M 0.02%
+80,000
New +$970K
2013 Q2
0 quarters
WNR
305
DELISTED
Western Refining Inc
WNR
$1.03M 0.02%
+36,719
New +$1.14M
2013 Q2
0 quarters
BA icon
306
Boeing
BA
$150B
$1.02M 0.02%
+10,000
New +$950K
2013 Q2
0 quarters
NES
307
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$1.01M 0.02%
+35,000
New +$1.21M
2013 Q2
0 quarters
DRE
308
DELISTED
Duke Realty Corp.
DRE
$1.01M 0.02%
+64,497
New +$1.1M
2013 Q2
0 quarters
PPLI icon
309
People Inc
PPLI
$3.04B
$1M 0.02%
+118,276
New +$1.01M
2013 Q2
0 quarters
WCG
310
DELISTED
Wellcare Health Plans, Inc.
WCG
$1M 0.02%
+18,000
New +$1.01M
2013 Q2
0 quarters
TLT icon
311
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.7B
$982K 0.02%
+130,000
New +$15.3M
2013 Q2
0 quarters
ETFC
312
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$978K 0.02%
+729,100
New +$8.04M
2013 Q2
0 quarters
GM.PRB icon
313
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
$958K 0.02%
+20,000
New +$937K
2013 Q2
0 quarters
FAST icon
314
Fastenal
FAST
$58.2B
$945K 0.02%
+82,404
New +$1.01M
2013 Q2
0 quarters
DMND
315
DELISTED
DIAMOND FOODS, INC.
DMND
$944K 0.02%
+45,500
New +$750K
2013 Q2
0 quarters
LORL
316
DELISTED
Loral Space and Communications, Inc.
LORL
$939K 0.02%
+15,652
New +$960K
2013 Q2
0 quarters
CYH icon
317
Community Health Systems
CYH
$389M
$938K 0.02%
+24,200
New +$911K
2013 Q2
0 quarters
NUWE icon
318
Nuwellis
NUWE
$2.19M
– –
0
– –
2013 Q2
0 quarters
OMTH
319
DELISTED
OMTHERA PHARMACEUTICALS INC COM STK (DE)
OMTH
$931K 0.02%
+70,000
New +$682K
2013 Q2
0 quarters
NPSP
320
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$912K 0.02%
+60,400
New +$837K
2013 Q2
0 quarters
ARRY icon
321
DELISTED
Array Biopharma Inc
ARRY
$908K 0.02%
+200,000
New +$1.08M
2013 Q2
0 quarters
EPR icon
322
EPR Properties
EPR
$4.19B
$894K 0.02%
+17,777
New +$965K
2013 Q2
0 quarters
TWO
323
DELISTED
Two Harbors Investment
TWO
$894K 0.02%
+10,905
New +$1M
2013 Q2
0 quarters
ARIA
324
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$874K 0.02%
+50,000
New +$886K
2013 Q2
0 quarters
OPTR
325
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$868K 0.02%
+60,000
New +$874K
2013 Q2
0 quarters

Similar funds

UBS O'Connor's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Pfizer: 6,269,077 shares worth $167M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, followed by Consumer Staples and Real Estate.

  • UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
  • UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
  • UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.

Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.